What Vetoquinol SA's (EPA:VETO) P/E Is Not Telling You
Nov 21
Have your own idea? Try our Stock Screener
French (CAC) Healthcare Sector Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies65
- 7D-1.1%
- 3M-2.2%
- 1Y10.2%
- YTD2.7%
Over the last 7 days, the Healthcare industry has dropped 1.4%, driven by a pullback from Sanofi of 3.7%. In the past year, the industry has gained 11%. Earnings are forecast to grow by 17% annually.
Sector Valuation and Performance
Has the French Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | €277.5b | €113.9b | €9.1b | 20.9x | 30.6x | 2.4x |
| Sat, 19 Oct 2024 | €291.3b | €112.5b | €8.8b | 23.2x | 33.1x | 2.6x |
| Mon, 16 Sep 2024 | €288.1b | €112.0b | €8.6b | 22x | 33.7x | 2.6x |
| Wed, 14 Aug 2024 | €277.9b | €111.8b | €8.6b | 22.8x | 32.3x | 2.5x |
| Fri, 12 Jul 2024 | €268.3b | €110.0b | €9.0b | 23.7x | 29.7x | 2.4x |
| Sun, 09 Jun 2024 | €274.5b | €110.0b | €9.0b | 25x | 30.4x | 2.5x |
| Tue, 07 May 2024 | €267.7b | €104.9b | €7.6b | 24.5x | 35.3x | 2.6x |
| Thu, 04 Apr 2024 | €275.5b | €104.7b | €8.6b | 20.6x | 32.1x | 2.6x |
| Sat, 02 Mar 2024 | €266.5b | €104.5b | €8.6b | 21.2x | 30.8x | 2.5x |
| Mon, 29 Jan 2024 | €264.5b | €104.0b | €12.7b | 21.2x | 20.8x | 2.5x |
| Wed, 27 Dec 2023 | €261.9b | €104.0b | €12.7b | 21.2x | 20.6x | 2.5x |
| Fri, 24 Nov 2023 | €250.3b | €104.0b | €12.7b | 20.7x | 19.7x | 2.4x |
| Sun, 22 Oct 2023 | €255.1b | €104.6b | €12.3b | 19.6x | 20.7x | 2.4x |
| Tue, 19 Sep 2023 | €275.7b | €104.8b | €12.4b | 21.4x | 22.3x | 2.6x |
| Thu, 17 Aug 2023 | €271.1b | €104.5b | €12.5b | 22.1x | 21.7x | 2.6x |
| Sat, 15 Jul 2023 | €263.5b | €103.8b | €12.4b | 19.6x | 21.2x | 2.5x |
| Mon, 12 Jun 2023 | €265.1b | €108.3b | €12.1b | 20x | 21.9x | 2.4x |
| Wed, 10 May 2023 | €277.7b | €108.3b | €12.1b | 21.3x | 23x | 2.6x |
| Fri, 07 Apr 2023 | €276.1b | €107.8b | €12.4b | 20.1x | 22.3x | 2.6x |
| Sun, 05 Mar 2023 | €260.8b | €107.7b | €12.8b | 19.9x | 20.4x | 2.4x |
| Tue, 31 Jan 2023 | €264.0b | €104.9b | €10.5b | 18.2x | 25.1x | 2.5x |
| Thu, 29 Dec 2022 | €264.6b | €104.9b | €10.5b | 17.8x | 25.2x | 2.5x |
| Sat, 26 Nov 2022 | €269.2b | €105.1b | €10.5b | 17.9x | 25.7x | 2.6x |
| Mon, 24 Oct 2022 | €245.5b | €102.5b | €10.4b | 17.4x | 23.7x | 2.4x |
| Wed, 21 Sep 2022 | €177.2b | €79.2b | €9.0b | 16.8x | 19.6x | 2.2x |
| Fri, 19 Aug 2022 | €194.2b | €78.9b | €9.0b | 20.8x | 21.5x | 2.5x |
| Sun, 17 Jul 2022 | €212.2b | €76.6b | €9.1b | 20.3x | 23.4x | 2.8x |
| Tue, 14 Jun 2022 | €200.0b | €76.4b | €9.2b | 18.5x | 21.8x | 2.6x |
| Thu, 12 May 2022 | €204.6b | €75.5b | €9.3b | 18.3x | 22.1x | 2.7x |
| Sat, 09 Apr 2022 | €226.9b | €74.4b | €8.7b | 21x | 26.1x | 3.1x |
| Mon, 07 Mar 2022 | €194.0b | €73.6b | €8.5b | 17.9x | 22.8x | 2.6x |
| Wed, 02 Feb 2022 | €209.8b | €71.8b | €8.5b | 18.9x | 24.6x | 2.9x |
| Fri, 31 Dec 2021 | €229.1b | €71.8b | €8.5b | 24.4x | 26.9x | 3.2x |
| Sun, 28 Nov 2021 | €227.4b | €71.8b | €8.5b | 22.5x | 26.8x | 3.2x |
Price to Earnings Ratio
26.8x
Current Industry PE
- Investors are optimistic on the French Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 30.7x which is higher than its 3-year average PE of 25.1x.
- The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 2.2% per year over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the French Healthcare sector?
| FR Market | -0.34% | |
| Healthcare | -1.06% | |
| Medical Equipment | 2.73% | |
| Pharma | -3.40% | |
| Healthtech | -4.15% | |
| Life Sciences | -4.68% | |
| Healthcare Services | -5.52% | |
| Biotech | -7.73% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 40.0x.
- Analysts are expecting annual earnings growth of 27.2%, which is higher than its past year's earnings decline of 33.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 27% over the next 5 years.
- This is better than its past earnings decline of 34% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings decline by 12% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| EL EssilorLuxottica Société anonyme | €233.80 | 3.5% +€3.6b | 30.7% | PE46.5x | |
| ERF Eurofins Scientific | €45.86 | 2.0% +€168.5m | -11.4% | PE26.6x | |
| BLC Bastide Le Confort Médical | €19.90 | 13.7% +€17.5m | -18.4% | PE19.7x | |
| IVA Inventiva | €2.58 | 4.9% +€10.4m | -30.8% | PS11.7x | |
| MAAT MaaT Pharma | €8.24 | 9.6% +€10.0m | 12.9% | PS44.6x |
